hV01
AXP000103.1 · Oncolytic virus
- Platform
- vaccinia virus
- Originator
- Hangzhou Converd
- Sponsor
- Hangzhou Converd
Names
| Name | Type | Source |
|---|---|---|
| hV01 | preferred name, code | curator, ctgov |
| Recombinant human IL-21-expressing oncolytic vaccinia virus injection | synonym | ctgov |
Virus
- Role
- Oncolytic
- Family
- Poxviridae
- Virus
- vaccinia virus (NCBI Taxonomy 10245)
- Replication
- conditionally replicating
- Modifications
- not described in the registration
- Transgenes
- IL21
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (3)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT07185243 | A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors. | Recruiting | 2025-06-23 | 2027-06 | 24 | Advanced Solid Tumors | |
| NCT07006077 | Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer | Recruiting | Phase 2 | 2025-05-29 | 2028-12-31 | 12 | Advanced Pancreatic Cancer |
| NCT05914376 | Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors | Active not recruiting | Phase 1 | 2023-07-05 | 2025-07-02 | 24 | Advanced Solid Tumors |
Recent changes
No changes recorded in its trials yet.
Clinical papers
No confirmed clinical papers yet.
Other papers
Preclinical studies, reviews and other papers that name it.
No confirmed other papers yet.
Unconfirmed matches (2)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 37444858 | Manufacturing Process, Microstructure and Physico-Mechanical Properties of W-Cr Coatings Reinforced by Cr3C2 Phase Produced on Tool Steel through Laser Processing. | Materials (Basel, Switzerland) | 2023 | name in abstract: hV01 |
| PMID 34501009 | Printable and Machinable Dental Restorative Composites for CAD/CAM Application-Comparison of Mechanical Properties, Fractographic, Texture and Fractal Dimension Analysis. | Materials (Basel, Switzerland) | 2021 | name in abstract: hV01 |
Notes
Recombinant human IL-21-expressing oncolytic vaccinia virus injection; phase 1 in advanced solid tumours (NCT05914376, active) and a phase 2 in pancreatic cancer. Route not stated in the registration.
How to cite
hV01 (AXP000103.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000103.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.